Therapeutics to harness the immune microenvironment in multiple myeloma

por Ignatz-Hoover, James J., Driscoll, James J.
Publicado 2022

Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes

por Ignatz-Hoover, James J., Murphy, Elena V., Driscoll, James J.
Publicado 2022

Current and Emerging Strategies to Treat Urothelial Carcinoma

por Rani, Berkha, Ignatz-Hoover, James J., Rana, Priyanka S., Driscoll, James J.
Publicado 2023

Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma

por Swamydas, Muthulekha, Murphy, Elena V., Ignatz-Hoover, James J., Malek, Ehsan, Driscoll, James J.
Publicado 2022

Novel therapies emerging in oncology to target the TGF-β pathway

por Kim, Byung-Gyu, Malek, Ehsan, Choi, Sung Hee, Ignatz-Hoover, James J., Driscoll, James J.
Publicado 2021

The role of TLR8 signaling in Acute Myeloid Leukemia Differentiation

por Ignatz-Hoover, James J, Wang, Huaiyu, Moreton, Stephen A, Chakrabarti, Amit, Agarwal, Mukesh K, Sun, Kevin, Gupta, Kalpana, Wald, David N
Publicado 2014

Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma

por Malek, Ehsan, Rana, Priyanka S., Swamydas, Muthulekha, Daunov, Michael, Miyagi, Masaru, Murphy, Elena, Ignatz-Hoover, James J., Metheny, Leland, Seong Jin, Kim, Driscoll, James J.
Publicado 2023

Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia

por Ueda, Masumi, Stefan, Tammy, Stetson, Lindsay, Ignatz-Hoover, James J., Tomlinson, Benjamin, Creger, Richard J., Cooper, Brenda, Lazarus, Hillard M., de Lima, Marcos, Wald, David N., Caimi, Paolo F.
Publicado 2020